PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global wound biologics market by skin substitutes • Global wound biologics market by growth factors PART 07: Geographical segmentation • Wound biologics market in Americas • Wound biologics market in EMEA • Wound biologics market in APAC PART 08: Market drivers • Prevalence of chronic diseases • Availability of different skin substitutes • Rise in geriatric population PART 09: Impact of drivers PART 10: Market challenges • Limited availability of clinical data • Availability of alternatives • Stringent regulatory approval process PART 11: Impact of drivers and challenges PART 12: Market trends • Advances in technology • Increase in pipeline products • Demand for combination dressings • Emergence of new treatment options PART 13: Vendor landscape • Competitive scenario • Key news • Mergers and acquisitions • Market share analysis 2015 • Smith & Nephew • Organogenesis • Acelity • Integra LifeSciences • Other prominent vendors PART 14: Appendix • List of abbreviations PART 15: Explore Technavio   LOE Exhibit 01: Product offerings Exhibit 02: Stages of wound healing Exhibit 03: Types of wounds Exhibit 04: Global wound biologics market 2015-2020 ($ billions) Exhibit 05: Five forces analysis Exhibit 06: Global wound biologics market segmentation by product Exhibit 07: Global wound biologics market by skin substitutes 2015-2020 ($ millions) Exhibit 08: Growth factors involved in wound healing Exhibit 09: Global wound biologics market by growth factors 2015-2020 ($ millions) Exhibit 10: Global wound biologics market segmentation by geography 2015 Exhibit 11: Wound biologics market in Americas 2015-2020 ($ millions) Exhibit 12: Wound biologics market in EMEA 2015-2020 ($ millions) Exhibit 13: Wound biologics market in APAC 2015-2020 ($ millions) Exhibit 14: Global wound biologics market segmentation by geography 2015-2020 ($ millions) Exhibit 15: Global wound biologics market segmentation by geography 2015-2020 Exhibit 16: Different commercially available skin substitutes Exhibit 17: Impact of drivers Exhibit 18: Impact of drivers and challenges Exhibit 19: Middle- and late-stage wound biologics in pipeline Exhibit 20: Ranking of vendors 2015 Exhibit 21: Market share of vendors 2015 Exhibit 22: Smith & Nephew: Business segmentation by revenue 2014 Exhibit 23: Smith & Nephew: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 24: Smith & Nephew: Key takeaways Exhibit 25: Organogenesis: Key takeaways Exhibit 26: Acelity: Business segmentation by revenue 2014 Exhibit 27: Acelity: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 28: Acelity: Key takeaways Exhibit 29: Integra LifeSciences: Key takeaways

Acelity, Integra LifeSciences, Organogenesis, Smith & Nephew, Avita Medical, BioDlogics, ConvaTec, Cytori Therapeutics, Intercytex, MacroCure, Molyncke Health Care, Nuo Therapeutics, Osiris Therapeutics, Regenerys.